3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Pain, Postoperative
4
Breast Neoplasms
3
Pain
2
Lung Neoplasms
2
Uterine Cervical Dysplasia
1
Thyroid Neoplasms
1
Supratentorial Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Postoperative Hemorrhage
1
Nerve Block
1
Musculoskeletal Diseases
1
Mouth Neoplasms
1
Malignant Neoplasms of Male Genital Organs
1
Hypotension
1
Head and Neck Neoplasms
1
Goiter
1
Chronic Pain
1
Carcinoma, Renal Cell
1
Bowen's Disease
1
Agnosia
1
Acute Upper Gastrointestinal Bleeding
1
Acute Pain
1
Interventions
Cisplatin
17
Radiotherapy
11
Cetuximab
11
Surveys and Questionnaires
10
pembrolizumab
9
Biopsy
9
Radiation
8
Magnetic Resonance Spectroscopy
8
Drug Therapy
8
Surgical Procedures, Operative
7
Radiotherapy, Intensity-Modulated
7
Carboplatin
7
X-Rays
6
Specimen Handling
6
Fluorouracil
6
Celecoxib
6
Standard of Care
5
Paclitaxel
5
Observation
5
Sentinel Lymph Node Biopsy
4
Interviews as Topic
4
Chemoradiotherapy
4
1,2-diaminocyclohexaneplatinum II citrate
4
Watchful Waiting
3
Ultrasonography
3
Taxes
3
Practice Guidelines as Topic
3
Positron Emission Tomography Computed Tomography
3
Platinum
3
Optical Imaging
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Mouth Neoplasms
×
Epinephrine
×
Clear all
NCT01418118
2011-08-16
Free4Flow
Oxford University Hospitals NHS Trust
Phase 4
Completed
25 enrolled